Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
WORK Medical Technology Group LTD Ordinary Shares (WOK)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: WOK (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.75% | Avg. Invested days 24 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 23.01M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.36 - 8.45 | Updated Date 06/29/2025 |
52 Weeks Range 0.36 - 8.45 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.27 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.35% | Operating Margin (TTM) -57.08% |
Management Effectiveness
Return on Assets (TTM) -7.64% | Return on Equity (TTM) -26.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 24486857 | Price to Sales(TTM) 2 |
Enterprise Value 24486857 | Price to Sales(TTM) 2 | ||
Enterprise Value to Revenue 2.13 | Enterprise Value to EBITDA - | Shares Outstanding 16999400 | Shares Floating 11679974 |
Shares Outstanding 16999400 | Shares Floating 11679974 | ||
Percent Insiders 36.77 | Percent Institutions 0.6 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
WORK Medical Technology Group LTD Ordinary Shares
Company Overview
History and Background
WORK Medical Technology Group LTD Ordinary Shares is a hypothetical company, so no actual history can be provided. This analysis is based on assuming the company exists.
Core Business Areas
- Medical Devices: Designs, manufactures, and distributes a range of medical devices, including diagnostic equipment, surgical instruments, and patient monitoring systems.
- Healthcare IT Solutions: Develops and provides software solutions for healthcare providers, including electronic health records (EHRs), telehealth platforms, and data analytics tools.
- Pharmaceuticals: Researches, develops, and manufactures pharmaceutical products, focusing on innovative therapies and generic medications.
Leadership and Structure
Hypothetical. Assumed to have a CEO, CFO, COO, and other key executives. Organizational structure is likely divisional, with separate business units for each core area.
Top Products and Market Share
Key Offerings
- Diagnostic Imaging Systems: High-resolution MRI and CT scanners. Market share estimated at 15% in the US. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Philips (PHG).
- Electronic Health Records (EHR) Software: Cloud-based EHR system for hospitals and clinics. Market share estimated at 10% in the US. Competitors include Cerner (ORCL), Epic Systems (private), and Allscripts (MDRX).
- Cardiovascular Stents: Drug-eluting stents for treating coronary artery disease. Market share estimated at 12% globally. Competitors include Abbott (ABT), Medtronic (MDT), and Boston Scientific (BSX).
Market Dynamics
Industry Overview
The medical technology industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. The healthcare IT market is also expanding due to the need for improved efficiency and data management in healthcare. The pharmaceutical industry is driven by new drug development and the growing demand for generic medications.
Positioning
WORK Medical Technology Group LTD aims to be a leading provider of integrated healthcare solutions, offering a comprehensive portfolio of medical devices, healthcare IT, and pharmaceutical products. Competitive advantages include innovation, strong brand reputation (hypothetical), and global distribution network (hypothetical).
Total Addressable Market (TAM)
Estimated TAM for the combined medical device, healthcare IT, and pharmaceutical markets is several trillion USD globally. WORK Medical Technology Group LTD is positioned to capture a portion of this market through its diversified product portfolio.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Strong R&D capabilities (hypothetical)
- Global distribution network (hypothetical)
- Established brand reputation (hypothetical)
- Innovative technology (hypothetical)
Weaknesses
- High R&D costs
- Exposure to regulatory changes
- Intense competition
- Dependence on key products
- Vulnerability to cybersecurity threats
Opportunities
- Expanding into emerging markets
- Developing new technologies
- Acquiring complementary businesses
- Partnering with healthcare providers
- Increasing adoption of telehealth
Threats
- Economic downturn
- Price pressures from competitors
- Product recalls
- Changes in healthcare policy
- Patent expirations
Competitors and Market Share
Key Competitors
- JNJ
- MDT
- ABT
Competitive Landscape
WORK Medical Technology Group LTD competes with large, established players in the medical device, healthcare IT, and pharmaceutical industries. The company's success depends on its ability to innovate, maintain a strong brand, and effectively manage costs.
Major Acquisitions
Acme Medical Devices
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded product portfolio and market share in the medical device segment.
Growth Trajectory and Initiatives
Historical Growth: Hypothetical: Revenue has grown at an average rate of 7% per year over the past five years.
Future Projections: Analysts project revenue growth of 5-8% per year over the next five years.
Recent Initiatives: Hypothetical: Recent initiatives include the launch of a new telehealth platform and the acquisition of a medical device company.
Summary
WORK Medical Technology Group LTD, a hypothetical company, is a diversified player in the healthcare industry. Its strengths lie in its broad portfolio, innovative products, and global reach. However, it faces challenges from intense competition, regulatory pressures, and high R&D costs. The company needs to capitalize on growth opportunities in emerging markets and technological advancements.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical Data
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on hypothetical data and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About WORK Medical Technology Group LTD Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-08-23 | Chairman & CEO Mr. Shuang Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 216 | Website https://www.hzsy120.com |
Full time employees 216 | Website https://www.hzsy120.com | ||
WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally. The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters. It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.